Literature DB >> 3708565

Effect of 3-methylcholanthrene on atherosclerosis in two congenic strains of mice with different susceptibilities to methylcholanthrene-induced tumors.

B Paigen, P A Holmes, A Morrow, D Mitchell.   

Abstract

Inbred mouse strains AKXL-38 and AKXL-38a are congenic strains that differ at the Ah locus, a gene which affects the inducibility of the cytochrome P-450 enzymes. The Ah-responsive strain, AKXL-38a, is more susceptible to 3-methylcholanthrene-induced tumors than the Ah-nonresponsive strain, AKXL-38. We previously reported that 3-methylcholanthrene (MC) increased the number and the size of atherosclerotic lesions in a dose-dependent fashion. We now demonstrate that the effect of MC is greater in Ah-responsive mice than in Ah-nonresponsive mice indicating that Ah-responsive mice not only are more susceptible to MC-induced cancer but also are more susceptible to MC-enhanced atherosclerosis. Mice that received atherogenic diet for 14 weeks but no MC had 1.3-1.4 lesions/mouse regardless of genetic type. When mice were treated with MC, the number of lesions increased to 2.1 +/- 0.1 (SE) in Ah-nonresponsive mice, 2.6 +/- 0.2 in Ah-responsive mice, and 2.3 +/- 0.2 in the F1 hybrid. The total area involved in lesions was 9.3-12.6 micron2 in untreated animals. When mice were treated with MC, the total lesion area increased to 23.5 +/- 5.2 micron2 in Ah-nonresponsive mice, to 43.9 +/- 6.6 micron2 in Ah-responsive mice, and to 36.2 +/- 4.8 micron2 in F1 hybrids. Thus MC increased the lesion area in both strains of mice, but the increase was significantly greater in Ah-responsive than in Ah-nonresponsive animals. High density lipoprotein levels were not significantly affected by MC treatment or Ah genotype. In order to determine whether the increased susceptibility to MC-induced atherosclerosis segregated with the Ah gene, AKXL-38 and AKXL-38a mice were mated and the F1 progeny were backcrossed to the Ah-nonresponsive parent. Backcross progeny were tested for Ah genotype by zoxazolamine sleeping time. Measurements of lesions showed that increased susceptibility to MC-enhanced atherosclerosis segregated with the Ah locus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708565

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.

Authors:  G B Gordon; D E Bush; H F Weisman
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

2.  Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice.

Authors:  Petra A Prins; Prudhvidhar R Perati; Valentina Kon; Zhongmao Guo; Aramandla Ramesh; MacRae F Linton; Sergio Fazio; Uchechukwu K Sampson
Journal:  Cell Physiol Biochem       Date:  2012-03-01

3.  Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: a possible role in atherogenesis.

Authors:  M J Thirman; J H Albrecht; M A Krueger; R R Erickson; D L Cherwitz; S S Park; H V Gelboin; J L Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

4.  Discovery of characteristic molecular signatures for the simultaneous prediction and detection of environmental pollutants.

Authors:  Mi-Kyung Song; Han-Seam Choi; Yong-Keun Park; Jae-Chun Ryu
Journal:  Environ Sci Pollut Res Int       Date:  2013-11-07       Impact factor: 4.223

5.  Overexpression of antioxidant enzymes in ApoE-deficient mice suppresses benzo(a)pyrene-accelerated atherosclerosis.

Authors:  Hong Yang; LiChun Zhou; Zefen Wang; L Jackson Roberts; Xinghua Lin; Yanfeng Zhao; ZhongMao Guo
Journal:  Atherosclerosis       Date:  2009-04-11       Impact factor: 5.162

6.  Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice.

Authors:  Chi Young Song; Khuzema Ghafoor; Hafiz U Ghafoor; Nayaab S Khan; Shyamala Thirunavukkarasu; Brett L Jennings; Anne M Estes; Sahar Zaidi; Dave Bridges; Patrick Tso; Frank J Gonzalez; Kafait U Malik
Journal:  Hypertension       Date:  2015-11-16       Impact factor: 10.190

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.